ATC code A07BB (WHO) CAS Number 99-26-3 ChemSpider 10607905 | Legal status US: OTC PubChem CID 16682999 | |
 | ||
AHFS/Drugs.com International Drug Names | ||
Bismuth subgallate, with a chemical formula C7H5BiO6, is commonly used to treat malodor by deodorizing flatulence and stools. In the United States it is the active ingredient in Devrom (internal deodorant), an over-the-counter FDA-approved medicine. Also, it has been used to treat Helicobacter pylori infection and is used in wound therapy. As an internal deodorant, it is commonly used by individuals who have had gastrointestinal stoma surgery, bariatric surgery, fecal incontinence, and irritable bowel syndrome.
Also, a double blind study in 1974 reported its effectiveness as a flatulence/stool deodorant in ileostomy patients.
Adverse effects
It can cause darkening of the tongue and stools, which is temporary.
In 1974, a reversible encephalopathy was noted and examined in four colon cancer patients taking bismuth subgallate after abdominoperineal resection.
Bismuth subgallate is contraindicated in case of hypersensitivity to the substance, and should be used with caution in people with liver disease or kidney disease. It is grouped in pregnancy category C (risk not ruled out: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks). During lactation, very little bismuth subgallate passes over to the child.